NervGen Pharma Partners with Imeka to Use Novel Neuroimaging Technology in Clinical Trials
VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage today announced… Read More




